Ellen Feigal

Prescient Therapeutics Limited | Non-Executive Director

Dr Feigal is currently a Partner and Head of the Biologics practice at global life sciences advisory firm, NDA Partners LLC. She was formerly Senior Vice President overseeing research and development with the California Institute of Regenerative Medicine. She is a member of the Governance Committee.

Company and Role

Company	Title	Tenure	Since
PTX Prescient Therapeutics Limited	Non-Executive Director	3yrs, 5mth	May 2023

Holding

Company	Last Notice	Direct Shares	Indirect Shares	Options	Convertibles
PTX Prescient Therapeutics Limited	20/08/26	N/A	N/A	2,628,787	N/A

Transactions

Company	Date	Type	Amount	Price	Value	Notes
PTX Prescient Therapeutics Limited	18/11/25	Issued	1,213,787	$0.048	$58,261	Issue of options

Any feedback about this profile? Contact Us

Build your watchlist

Already have account? Log in